Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.
about
Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressorHuman cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscleMonitoring immediate-early gene expression through firefly luciferase imaging of HRS/J hairless miceReactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus.Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer.Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirusAn essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis.Viral enhancer mimicry of host innate-immune promoters.Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirusMurine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic miceNeurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice.The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.Developmental analysis of the cytomegalovirus enhancer in transgenic animals.Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice.Msx2 exerts bone anabolism via canonical Wnt signaling.In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1.The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infectionRegulated gene expression in the chicken embryo by using replication-competent retroviral vectors.Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune systemNeurons differentially activate the herpes simplex virus type 1 immediate-early gene ICP0 and ICP27 promoters in transgenic mice.Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain.
P2860
Q24648833-D6D62003-660E-46AF-AB53-9915DBBB7F1BQ24795634-93FA551D-D24F-4409-A522-09FA5DB83523Q24799895-3A3A873A-44BD-4FA5-ACE7-D350ABB16D64Q33781921-A15030D1-DA9B-4569-94BE-0B4BAF069741Q33783897-35E327BC-41C4-41F3-811E-74EF9B157949Q33785172-909402F7-8228-427D-974C-E000CEADB3A5Q33800239-687C45B4-C1CC-4D9B-BBB2-26B2B1FF4B6CQ33814326-13BF1714-7754-48C7-ABA8-8E9290DE24ADQ34755471-2B6F1E55-3C3A-4488-93A3-0FBF1D083A04Q35091211-24414C0D-D5B6-44FA-AF70-61D4E8CDDA5FQ35764082-78718955-40C5-4371-9831-90941801D8FFQ35786286-FE486598-5862-4274-8252-8592F63F4E94Q35852461-FBF3BD7B-83BE-490E-B57B-4D95E516FA99Q35860573-534E3164-9719-43E4-AA05-88C6B3ABED07Q35860583-04A78F13-883A-4A0B-B9AC-87C8ABCA5F21Q36673418-283CD8F9-0A51-4DFE-BA2E-99FBF5E8CF38Q36761867-2C44B45B-98EF-49DF-8E49-700EB6974E36Q36934017-7F8DFCE6-B932-471D-AED0-1F3A75B947F9Q37406553-B783C192-A998-4D35-BF30-1F2985BE0C2EQ39604733-854BDB93-1ECB-4208-9B61-7D21C147A2B4Q39627859-7B7AB156-BED3-4E15-A279-C8E85197194EQ39682559-0B24E58B-D376-43C8-866E-FD6C09A3E970Q39686645-072D8E76-384A-4FA1-B50F-DC9EDB43086FQ39748037-D443EA80-C1F6-4256-B639-0D59817867B9Q42957459-53AB9CD2-921F-44A4-9A5E-87A1C53D9E55
P2860
Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Human cytomegalovirus (HCMV) i ...... of congenital HCMV infection.
@ast
Human cytomegalovirus (HCMV) i ...... of congenital HCMV infection.
@en
type
label
Human cytomegalovirus (HCMV) i ...... of congenital HCMV infection.
@ast
Human cytomegalovirus (HCMV) i ...... of congenital HCMV infection.
@en
prefLabel
Human cytomegalovirus (HCMV) i ...... of congenital HCMV infection.
@ast
Human cytomegalovirus (HCMV) i ...... of congenital HCMV infection.
@en
P2093
P2860
P1433
P1476
Human cytomegalovirus (HCMV) i ...... s of congenital HCMV infection
@en
P2093
P2860
P304
P577
1995-04-01T00:00:00Z